October 24, 2016
Genotype 5 is the least common hepatitis C subtype, comprising less than 1% of global infections. Nonetheless, it is the most common type of infection in Southern Africa, where it represents more than half of all infections.
Although fewer clinical studies have been conducted with patients who have genotype 5 infection, current guidelines suggest that genotype 5 patients with or without liver damage should start treatment with sofosbuvir/ledipasvir or sofosbuvir/velpatasvir.
Credit: naruedom for iStock via Thinkstock.
Sony Salzman is a freelance journalist reporting on health care and medicine, who has won awards in both narrative writing and radio journalism. Follow Salzman on Twitter: @sonysalz.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|HIV Vaccine Induces Sustained HIV Remission in Proof-of-Concept Study|
|Incidence of All Cancers but Lung Cancer Drops After HIV Group Stops Smoking|
|New HIV Capsid Inhibitor Strongly Stops HIV Replication at Two Steps|
|PrEP Failure Case Underscores Importance of Regular HIV Testing|
|What's Your Message to the Trump Administration About the Fight Against HIV?|
|Classic Risk Factors Drive Heart Attack Rates More Than HIV Variables|